CSPC Pharmaceutical Group's total assets for Q2 2024 were ¥47.87B, an increase of 3.75% from the previous quarter. HK:1093 total liabilities were ¥11.42B for the fiscal quarter, a 4.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.